|1.||Horiuchi, Masatsugu: 1 article (05/2007)|
|2.||Imura, Yoshimi: 1 article (05/2007)|
|3.||Iwai, Masaru: 1 article (05/2007)|
|4.||Chen, Rui: 1 article (05/2007)|
05/01/2007 - "TAK-536, a new AT1 receptor blocker, improves glucose intolerance and adipocyte differentiation."
05/01/2007 - "These results indicate the greater beneficial effects of TAK-536 in improving glucose intolerance, insulin sensitivity, and induction of adipocyte differentiation, and suggest that TAK-536 is advantageous as a new ARB for treatment of metabolic syndrome."
05/01/2007 - "These effects of TAK-536 on glucose intolerance were stronger than those of candesartan. "
|3.||candesartan cilexetil (Amias)